Results 11 to 20 of about 2,021,559 (378)

Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction [PDF]

BMC Cardiovascular Disorders
Background Heart failure with improved ejection fraction (HFimpEF) has been regarded as a new heart failure (HF) type in 2022. However, studies on the impact of left ventricular ejection fraction (LVEF) trajectories on the prognosis of patients with ...
Yang Jiang, Xuefu Chen, Xinxin Zhang, Shuang Dong, Ying Liu   +4 more
doaj   +4 more sources

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis [PDF]

Frontiers in Cardiovascular Medicine, 2021
Aims: Evidence-based guidelines for heart failure management depend mainly on current left ventricular ejection fraction (LVEF). However, fewer studies have examined the impact of prior LVEF.
Xinxin Zhang, Yuxi Sun, Yanli Zhang, Feifei Chen, Shuyuan Zhang, Hongyan He, Shuang Song, Gary Tse, Gary Tse, Ying Liu   +9 more
doaj   +4 more sources

Determinants of ejection fraction improvement in heart failure patients with reduced ejection fraction

ESC Heart Failure, 2023
Aims This study aimed to investigate the prognostic value of dynamic changes in left ventricular ejection fraction (EF) for cardiovascular (CV) outcomes in an all‐comer heart failure (HF) population with reduced EF (HFrEF, EF 4 vs.
Dan Liu, Kai Hu, Lena Schregelmann, Clara Hammel, Björn Daniel Lengenfelder, Georg Ertl, Stefan Frantz, Peter Nordbeck   +7 more
doaj   +3 more sources

Empagliflozin in Heart Failure with a Preserved Ejection Fraction. [PDF]

New England Journal of Medicine, 2021
BACKGROUND Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction ...
S. Anker, J. Butler, G. Filippatos, J. Ferreira, E. Bocchi, M. Böhm, H. Brunner-la Rocca, D. Choi, V. Chopra, E. Chuquiure-Valenzuela, N. Giannetti, J. Gómez-Mesa, S. Janssens, J. Januzzi, J. González-Juanatey, B. Merkely, S. Nicholls, S. Perrone, I. Piña, P. Ponikowski, M. Senni, D. Sim, J. Špinar, I. Squire, S. Taddei, H. Tsutsui, S. Verma, D. Vinereanu, Jian Zhang, P. Carson, Carolyn S. P. Lam, N. Marx, C. Zeller, N. Sattar, W. Jamal, S. Schnaidt, J. Schnee, M. Brueckmann, S. Pocock, F. Zannad, M. Packer   +40 more
semanticscholar   +8 more sources

Heart failure with preserved ejection fraction. [PDF]

Global Cardiology Science and Practice, 2012
Heart failure with preserved ejection fraction (HFpEF) has recently emerged as a major cause of cardiovascular morbidity and mortality. Contrary to initial beliefs, HFpEF is now known to be as common as heart failure with reduced ejection fraction (HFrEF)
ElGuindy, A, Yacoub, MH
core   +6 more sources

Ejection Fraction Revisited [PDF]

Anesthesiology, 1991
James L. Robotham, Masao Takata, Michael R. Berman, Yasuhiko Harasawa   +3 more
openalex   +4 more sources

Biomarker profiles of acute heart failure patients with a mid-range ejection fraction [PDF]

, 2017
OBJECTIVES: In this study, the authors used biomarker profiles to characterize differences between patients with acute heart failure with a midrange ejection fraction (HFmrEF) and compare them with patients with a reduced (heart failure with a ...
Bloomfield, Daniel M, Cleland, John G.F., Cotter, Gad, Davison, Beth, Dittrich, Howard C, Givertz, Michael M, Hillege, Hans L, Khan, Mohsin A F, Mentz, Robert J, Metra, Marco, O'Connor, Christopher M, Ponikowski, Piotr, Teerlink, John R, Tromp, Jasper, van der Meer, Peter, Van Veldhuisen, Dirk J, Voors, Adriaan A.   +16 more
core   +13 more sources

Blood Immune Cell Alterations in Patients with Hypertensive Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction

Journal of Cardiovascular Development and Disease, 2023
(1) Background: Chronic inflammation and fibrosis are key players in cardiac remodeling associated with left ventricular hypertrophy (LVH) and heart failure with a preserved ejection fraction (HFpEF). Monocytes and T-helpers (Th) are involved in both pro-
Artem Ovchinnikov, Anastasiya Filatova, Alexandra Potekhina, Tatiana Arefieva, Anna Gvozdeva, Fail Ageev, Evgeny Belyavskiy   +6 more
doaj   +1 more source

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.

New England Journal of Medicine, 2023
BACKGROUND Heart failure with preserved ejection fraction is increasing in prevalence and is associated with a high symptom burden and functional impairment, especially in persons with obesity.
M. Kosiborod, S. Z. Abildstrom, B. Borlaug, J. Butler, S. Rasmussen, M. Davies, G. Hovingh, D. Kitzman, M. Lindegaard, D. Møller, Sanjiv J. Shah, M. Treppendahl, S. Verma, W. Abhayaratna, F. Ahmed, V. Chopra, J. Ezekowitz, Michael Fu, Hiroshi Ito, M. Lelonek, V. Melenovský, B. Merkely, Julio Núñez, E. Perna, M. Schou, M. Senni, K. Sharma, P. van der Meer, Dirk von Lewinski, Dennis Wolf, M. Petrie   +30 more
semanticscholar   +1 more source

The correlation of left atrial diameter with preserved ejection fraction, reduced ejection fraction, and mid‐range ejection fraction

Clinical Cardiology, 2023
AbstractBackgroundIn patients with heart failure, left atrial remodeling often occurs to varying degrees. Left atrial enlargement has been proved to be an important predictor of cardiovascular‐related adverse events. However, the relationship between left atrial diameter (LAD) with heart failure (HF) with preserved ejection fraction (HFpEF), reduced ...
Jing Lin, Huajui Wu, Tianwen Zhang
openaire   +2 more sources